Enecimo, Danzy Dhae F.

HRN: 22-57-87  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/06/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
02/06/2023
02/13/2023
IV
140mg
Q6hrs
AGE
Waiting Final Action 

Indication:  Empiric Then Culture-directed    Type of Infection:  Intra-abdominal    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: